These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prenatal gene tranfer: scientific, medical, and ethical issues: a report of the Recombinant DNA Advisory Committee. U.S. National Institutes of Health. Recombinant DNA Advisory Committee Hum Gene Ther; 2000 May; 11(8):1211-29. PubMed ID: 11660775 [No Abstract] [Full Text] [Related]
3. Federal regulations for fetal research: a case for reform. Fletcher JC; Ryan KJ Law Med Health Care; 1987; 15(3):126-38. PubMed ID: 3695575 [No Abstract] [Full Text] [Related]
5. Recombinant DNA Advisory Committee: minutes of meeting, 1-2 Dec 1994 -- Parts VII and XV: ethical considerations relative to in utero somatic cell and gene therapies (discussion and presentation). U.S. National Institutes of Health. Recombinant DNA Advisory Committee Hum Gene Ther; 1995 Aug; 6(8):1065, 1077-1078, 1095-1097. PubMed ID: 11644759 [No Abstract] [Full Text] [Related]
6. Limitations of informed consent for in utero gene transfer research: implications for investigators and institutional review boards. Burger IM; Wilfond BS Hum Gene Ther; 2000 May; 11(7):1057-63. PubMed ID: 10811234 [TBL] [Abstract][Full Text] [Related]
7. Children as participants in medical research. Grodin MA; Alpert JJ Pediatr Clin North Am; 1988 Dec; 35(6):1389-401. PubMed ID: 3059305 [TBL] [Abstract][Full Text] [Related]
8. Research involving fetal drug therapy: ethical, legal, and practical considerations. Prentice ED; Rayburn WF Clin Obstet Gynecol; 1991 Jun; 34(2):360-8. PubMed ID: 1868643 [TBL] [Abstract][Full Text] [Related]
11. Fetal research: the state of the question. Fletcher JC; Schulman JD Hastings Cent Rep; 1985 Apr; 15(2):6-12. PubMed ID: 4008241 [TBL] [Abstract][Full Text] [Related]
12. Minutes of meeting: September 24-25, 1998. U.S. National Institutes of Health. Recombinant DNA Advisory Committee Hum Gene Ther; 2000 May; 11(7):1083-109. PubMed ID: 11645216 [No Abstract] [Full Text] [Related]
13. Ethical issues of perinatal human gene therapy. Fletcher JC; Richter G J Matern Fetal Med; 1996; 5(5):232-44. PubMed ID: 8930794 [TBL] [Abstract][Full Text] [Related]
14. Human fetal gene therapy: moral and ethical questions. Fletcher JC; Richter G Hum Gene Ther; 1996 Aug; 7(13):1605-14. PubMed ID: 8864761 [TBL] [Abstract][Full Text] [Related]
15. The greater good: fetuses destined for abortion may be used to test gene therapy. Cohen P New Sci; 1998 Oct; 160(2155):5. PubMed ID: 11657725 [No Abstract] [Full Text] [Related]
16. Ethical issues in recommending and offering fetal therapy. Chervenak FA; McCullough LB West J Med; 1993 Sep; 159(3):369-99. PubMed ID: 11643180 [No Abstract] [Full Text] [Related]
17. Fetal experimentation and federal regulation. Horan DJ Villanova Law Rev; 1977 Jan; 22(2):325-56. PubMed ID: 11664796 [No Abstract] [Full Text] [Related]
19. Minutes of meeting: March 11-12, 1999: Working Group III Report: ethical, legal, and societal issues. U.S. National Institutes of Health. Recombinant DNA Advisory Committee Hum Gene Ther; 2000 May; 11(8):1237-42. PubMed ID: 11645217 [No Abstract] [Full Text] [Related]
20. Constraints on experimentation: protecting children to death. Holder AR Yale Law Policy Rev; 1988; 6(1):137-56. PubMed ID: 11650241 [No Abstract] [Full Text] [Related] [Next] [New Search]